下颌前移矫治器治疗阻塞性睡眠呼吸暂停中咬合变化的预测因素 (APNEAMOUVE)
下颌前移矫治器治疗阻塞性睡眠呼吸暂停时牙齿咬合变化的预测因素评估
This research addresses obstructive sleep apnea syndrome (OSAS), affecting 6-12% of French adults, often treated with mandibular advancement devices (MADs). MADs may lead to occlusal modifications, causing a 50% treatment abandonment rate. The study employs surface electromyography to assess masticatory muscle activity before and during MAD use, correlating it with occlusal changes after 6 months. The primary goal is to determine dental displacement profiles post-6-month MAD treatment, providing insights for personalized care and minimizing treatment failures.
研究概览
详细说明
In this exploratory electro-pathophysiological study, our objective is to provide a significant contribution to understanding the underlying mechanisms of occlusal modifications associated with mandibular advancement device (MAD) treatment in patients suffering from obstructive sleep apnea syndrome (OSAS). Drawing from observational data, the researchers aim to identify specific electrophysiological profiles linked to masticatory muscle activity, correlating with occlusal changes after MAD treatment. This innovative approach involves detailed data collection on electrophysiological profiles, initial clinical characteristics pre-treatment, and post-treatment follow-up data. Focusing on patients from the dentistry department at Toulouse University Hospital, the study seeks to establish correlations between muscle activity recorded before and during MAD treatment and occlusal changes, ultimately defining electrophysiological patient profiles. These profiles could potentially guide personalized care, anticipating risks of occlusal modifications and reducing treatment dropouts or failures.
The study utilizes diverse exams-orthopantomogram, optical impressions, surface electromyography, polysomnography, and research questionnaires. Data collected pre- and post-mandibular advancement device treatment for six months will innovatively analyze the links between masticatory muscle activity and occlusal changes, aiming to define specific electrophysiological patient profiles.
In this research, participation in the protocol seamlessly integrates into routine care at the Odontology Department of the Toulouse University Hospital. The visits include the provision of the orthosis at 3 weeks (T1), with EMGs and digital occlusal analysis. The 6-week follow-up visit (T2) adjusts therapeutic propulsion, subjectively resolving symptoms related to OSAS. At the T0 visit, the researchers collect the polysomnographic monitoring before fitting the orthosis (carried out in the patient's reference sleep laboratory) to assess treatment efficiency.(The end-of-research visit (6 months after T0) comprehensively collects data, including questionnaires on stress, anxiety, sleep quality and quantity, oral habits, temporo mandibular dysfunction pain, and quality of life. Moreover, the researchers collect the polysomnographic monitoring after 3 months fitting the orthosis (carried out in the same patient's reference sleep laboratory than before fitting the orthosis).
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Constance CUNY, MD
- 电话号码:+33615282467
- 邮箱:cuny.c@chut-toulouse.fr
学习地点
-
-
-
Toulouse、法国
- 招聘中
- University Hospital of Toulouse
-
接触:
- Stéphanie BRAYER
- 电话号码:+33 5 61 32 25 09
- 邮箱:brayer.s@chu-toulouse.fr
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
patients with sleep apnea treated with a mandibular advancement device
描述
Inclusion Criteria:
- Patient with complete dentition (up to second molars)
- Polysomnography or polygraphy
- Diagnosis of OSA
- Patient receiving OAM treatment at the Odontology Department of Toulouse University Hospital
- Patient with contemporary panoramic and lateral cephalometric X-rays (common practice) taken at the time of orthotic treatment
- Individual affiliated with or covered by a social security scheme
- Voluntary, informed, written consent, signed by both participant and investigator (prior to inclusion and any necessary research-related examinations).
Exclusion Criteria:
- Inability to provide informed consent
- Pregnant or breastfeeding patient
- Patient with curators, guardians, or legal protection
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
OSA patients with mandibular advancement appliance
Patients with obstructive sleep apnea (OSA) treated with a mandibular advancement device (MAD), monitored for changes in masticatory muscle activity and occlusal modifications over a 6-month period. The study involves routine clinical visits and additional assessments including electromyography (EMG) with and without the appliance, optical impressions, digital occlusion recordings, patient diaries, and questionnaires on quality of life, temporo mandibular dysfunction pain, oral habits, stress and anxiety, and sleep evaluation. |
In this research, participation in the protocol seamlessly integrates into routine care at the Odontology Department of the University Hospital of Toulouse. The visits include the provision of the orthosis at 3 weeks (T1), with EMGs and digital occlusal analysis. The 6-week follow-up visit (T2) adjusts therapeutic propulsion, subjectively resolving symptoms related to OSAS. At the T0 visit, the researchers collect the polysomnographic monitoring before fitting the orthosis (carried out in the patient's reference sleep laboratory) to assess treatment efficiency. The end-of-research visit (6 months after T1) comprehensively collects data, including questionnaires on stress, anxiety, sleep quality and quantity, oral habits, temporo mandibular dysfunction pain, and quality of life. Moreover, the researchers collect the polysomnographic monitoring after 3 months fitting the orthosis (carried out in the same patient's reference sleep laboratory than before fitting the orthosis). |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
OCCLUSAL MODIFICATIONS AFTER 6 MONTHS OF OAM TREATMENT
大体时间:6 month
|
assessment of occlusal modifications after 6 months of mandibular advancement device (OAM) treatment. Dental occlusion will be measured using digital occlusal analysis with OCCLUSENS® (Bausch; Köln, Germany), considering the extent of contacts (centroid) and their intensity (%), and through morphometric analysis based on optical impressions obtained pre and post-treatment using the TRIOS optical camera (3Shape, Dentsply®) |
6 month
|
|
PRIMARY EXPOSURE VARIABLE: MASTICATORY MUSCLE ACTIVITY
大体时间:6 month
|
The primary exposure of interest is the activity of masticatory muscles measured by EMG, in the form of motor-evoked potentials (MEPs in µV/s). This measurement will be conducted at the T1 visit when the orthosis is provided to the patient (3 weeks after inclusion) and 6 months after the inclusion visit. At each measurement time, surface EMG will be conducted bilaterally (4 locations in total), both with and without OAM. The association between muscle activity at inclusion and occlusal modifications will be studied for the primary objective, while the association between muscle activity after 6 months of treatment and occlusal modifications will be explored as a secondary objective. |
6 month
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
OSA phenotype at T0 visit
大体时间:baseline
|
The phenotype is classified as:
|
baseline
|
|
initial sleep assesment
大体时间:baseline
|
Sleep will be assessed with polysomnography Oxygen desaturation index A normal oxygen saturation level should be about 96 to 97%. When blood oxygen levels drop below 90% Oxygen Desaturation Index is considered slightly abnormal. When blood oxygen levels dip even lower to 80 or 89%, they are considered moderately abnormal. Any blood oxygen levels below 80% are considered severe. |
baseline
|
|
Therapeutic mandibular advancement assessed at the T2 visit
大体时间:6 weeks
|
As a percentage of voluntary mandibular protrusion and in mm of advancement |
6 weeks
|
|
Titration modality assessed at the T2 visit
大体时间:6 weeks
|
Conventional and with a medical titration aid device |
6 weeks
|
|
difference in Patient's clinical characteristics at 6 months
大体时间:6 months
|
Difference in : - Body Mass Index (BMI), |
6 months
|
|
Clinical characteristics
大体时间:6 months
|
- Duration of MAD wear, |
6 months
|
|
Clinical characteristics
大体时间:6 months
|
- Frequency of MAD wear. |
6 months
|
|
Patient's quality of life
大体时间:baseline
|
Measured by the Short Form Survey (SF-36) |
baseline
|
|
Patient's quality of life
大体时间:6 months
|
Measured by the SF-36 questionnaire. Scoring the 36-Item Health Survey is a two-step process. First, all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. In step 2, items in the same scale are averaged together to create the 8 scale scores. Items that are left blank (missing data) are not taken into account when calculating the scale scores. Hence, scale scores represent the average for all items in the scale that the respondent answered. |
6 months
|
合作者和调查者
调查人员
- 首席研究员:Constance CUNY, MD、University Hospital, Toulouse
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.